Age-dependent effects on the treatment response of natalizumab in MS patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Age-dependent effects on the treatment response of natalizumab in MS patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 1, Pages 48-56
Publisher
SAGE Publications
Online
2014-05-28
DOI
10.1177/1352458514536085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
- (2013) Tomas Kalincik et al. BRAIN
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
- (2011) Carolina Holmén et al. Multiple Sclerosis Journal
- Age and disability accumulation in multiple sclerosis
- (2011) A. Scalfari et al. NEUROLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Evidence for a two-stage disability progression in multiple sclerosis
- (2010) E. Leray et al. BRAIN
- Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
- (2010) Emma C Tallantyre et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
- (2010) SA Morrow et al. Multiple Sclerosis Journal
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
- (2009) M. Hutchinson et al. JOURNAL OF NEUROLOGY
- Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
- (2009) AS Drake et al. Multiple Sclerosis Journal
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search